天賜材料(002709.SZ):與楚能新能源簽訂生產材料採購合作協議
格隆匯7月16日丨天賜材料(002709.SZ)公佈,2025年7月15日,廣州天賜高新材料股份有限公司全資子公司九江天賜高新材料有限公司(簡稱“九江天賜”)與武漢楚能新能源有限公司、孝感楚能新能源創新科技有限公司、宜昌楚能新能源創新科技有限公司(以下合稱“楚能新能源”)簽訂了《生產材料採購合作協議》。協議約定,在本協議有效期內(協議有效期限為自本協議生效之日起至2030年12月31日止),九江天賜向楚能新能源預計供應電解液系列產品總量不少於55萬噸。具體的合作項目以及對應的合作產品型號、供應量,由雙方另行簽訂備忘錄或補充協議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.